Trium Capital LLP Makes New $858,000 Investment in Zoetis Inc. $ZTS

Trium Capital LLP bought a new stake in Zoetis Inc. (NYSE:ZTS) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 5,863 shares of the company’s stock, valued at approximately $858,000.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Savvy Advisors Inc. raised its holdings in Zoetis by 54.0% during the 2nd quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock valued at $495,000 after acquiring an additional 1,114 shares during the period. Sound Income Strategies LLC grew its position in shares of Zoetis by 54.3% in the second quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after purchasing an additional 152 shares in the last quarter. Canoe Financial LP raised its stake in shares of Zoetis by 859.0% during the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock valued at $2,085,000 after purchasing an additional 11,975 shares during the period. Strs Ohio purchased a new stake in Zoetis during the 1st quarter worth about $22,891,000. Finally, Chicago Partners Investment Group LLC lifted its holdings in Zoetis by 67.0% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 4,886 shares of the company’s stock worth $750,000 after purchasing an additional 1,961 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on ZTS. BTIG Research reaffirmed a “buy” rating and set a $160.00 target price on shares of Zoetis in a report on Wednesday, December 3rd. JPMorgan Chase & Co. reduced their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Weiss Ratings cut shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday. Morgan Stanley set a $160.00 price target on shares of Zoetis in a report on Thursday, December 18th. Finally, Stifel Nicolaus decreased their price target on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Tuesday, November 18th. Six equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $160.18.

Zoetis Trading Up 1.6%

Shares of Zoetis stock opened at $125.50 on Friday. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.40. The firm has a market cap of $55.31 billion, a PE ratio of 21.13, a PEG ratio of 2.73 and a beta of 0.97. The company has a 50 day simple moving average of $127.41 and a two-hundred day simple moving average of $143.41.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be paid a $0.53 dividend. This is an increase from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, January 20th. Zoetis’s payout ratio is currently 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.